T1	Eq-Comparison 42 52	> 18 years
E1	Eq-Comparison:T1 Operator:T38 Value:T39 Temporal-Unit:T40
T2	Age 56 59	age
E2	Age:T2 Eq-Comparison:E1
T3	Assertion 79 93	clinical signs
E3	Assertion:T3 Asserted:E7
T4	Assertion 95 103	symptoms
E4	Assertion:T4 Asserted:E7
A1	Assertion-Type-Value E4 possible
T5	And 104 107	and
E5	And:T5 Arg:E4 Arg2:E6
T6	Assertion 108 120	presentation
E6	Assertion:T6 Asserted:E7
T7	Condition 143 153	thrombosis
E7	Condition:T7 Name:T42 Severity:T41
T8	Eq-Comparison 155 160	onset
E8	Eq-Comparison:T8 Temporal-Recency:T43
T9	Coreference 164 172	symptoms
E9	Coreference:T9 Refers-To:E7 Temporality:E8 Duration:E10
T10	Eq-Comparison 173 182	< 14 days
E10	Eq-Comparison:T10 Operator:T44 Value:T45 Temporal-Unit:T46
T11	Procedure 219 249	invasive endovenous procedures
E11	Procedure:T11 Name:T47
T12	Procedure 289 299	IVC filter
E12	Procedure:T12 Name:T48
T13	Procedure 314 321	treated
E13	Procedure:T13 
T14	Eq-Comparison 344 354	< 18 years
E14	Eq-Comparison:T14 Operator:T49 Value:T50 Temporal-Unit:T51
T15	Age 358 361	age
E15	Age:T15 Eq-Comparison:E14
T16	Condition 374 395	anaphylactic reaction
E16	Condition:T16 Name:T52
T17	Drug 399 427	radiographic contrast agents
E17	Drug:T17 Name:T53
T18	Assertion 433 439	cannot
E18	Assertion:T18 Asserted:E19
A3	Assertion-Type-Value E18 hypothetical
T19	Negation 433 439	cannot
E19	Negation:T19 Negates:E20
T20	Procedure 443 455	pre- treated
E20	Procedure:T20 
T21	Procedure 461 468	Imaging
E21	Procedure:T21 Name:T54
T22	Or 478 480	or
E22	Or:T22 Arg:E21 Arg2:E23
T23	Other 481 486	other
E23	Other:T23 
T24	Negation 529 532	not
E24	Negation:T24 Negates:E26
T25	Assertion 533 544	appropriate
E25	Assertion:T25 Asserted:E24
A4	Assertion-Type-Value E25 hypothetical
T26	Procedure 549 585	mechanical thrombectomy intervention
E26	Procedure:T26 Name:T55
T27	And 598 601	who
E27	And:T27 Arg:T56 Arg2:E28
T28	Condition 605 613	pregnant
E28	Condition:T28 Name:T57
T29	Or 614 616	or
E29	Or:T29 Arg:E28 Arg2:E30
T30	Condition 617 624	nursing
E30	Condition:T30 Name:T58
T32	Other 658 665	another
E32	Other:T32 Is-Other:E33
T33	Study 666 681	investigational
E33	Study:T33 Study-Of:E34
T34	Drug 682 686	drug
E34	Drug:T34 
T35	Or 687 689	or
E35	Or:T35 Arg:E34 Arg2:E36
T36	Procedure 690 706	device treatment
E36	Procedure:T36 
T37	Study 707 712	study
E37	Study:T37 Study-Of:E36
T38	Eq-Operator 42 43	>
A5	Eq-Operator-Value T38 GT
T39	Eq-Value 44 46	18
T40	Eq-Temporal-Unit 47 52	years
A6	Eq-Temporal-Unit-Value T40 year
T41	Severity 137 142	acute
A7	Severity-Value T41 severe
T42	Condition-Name 143 153	thrombosis
T43	Eq-Temporal-Recency 155 160	onset
A8	Eq-Temporal-Recency-Value T43 first-time
T44	Eq-Operator 173 174	<
A9	Eq-Operator-Value T44 LT
T45	Eq-Value 175 177	14
T46	Eq-Temporal-Unit 178 182	days
A10	Eq-Temporal-Unit-Value T46 day
T47	Procedure-Name 219 249	invasive endovenous procedures
T48	Procedure-Name 289 299	IVC filter
T49	Eq-Operator 344 345	<
A11	Eq-Operator-Value T49 LT
T50	Eq-Value 346 348	18
T51	Eq-Temporal-Unit 349 354	years
A12	Eq-Temporal-Unit-Value T51 year
T52	Condition-Name 374 395	anaphylactic reaction
T53	Drug-Name 399 427	radiographic contrast agents
T54	Procedure-Name 461 468	Imaging
T55	Procedure-Name 549 585	mechanical thrombectomy intervention
T56	Life-Stage-And-Gender 591 597	Female
A13	Life-Stage-And-Gender-Type T56 female
T57	Condition-Name 605 613	pregnant
T58	Condition-Name 617 624	nursing
A15	Assertion-Type-Value E3 possible
A16	Assertion-Type-Value E6 possible
T60	Assertion 197 218	cleared medically for
E38	Assertion:T60 Asserted:E11
A2	Assertion-Type-Value E38 hypothetical
T61	Assertion 308 313	to be
E39	Assertion:T61 Asserted:E13
A17	Assertion-Type-Value E39 hypothetical
T62	Modifier 303 307	area
E40	Modifier:T62 Modifies:T48 Modifies2:E13
R1	Caused-By Arg1:E16 Arg2:E17	
R2	Treatment-For Arg1:E20 Arg2:E16	
R3	Found-By Arg1:E24 Arg2:E21	
T31	Modifier 630 640	Concurrent
E31	Modifier:T31 Modifies:E33 Modifies2:E37
